123 related articles for article (PubMed ID: 16234529)
1. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate.
Fiore M; Miceli R; Mussi C; Lo Vullo S; Mariani L; Lozza L; Collini P; Olmi P; Casali PG; Gronchi A
J Clin Oncol; 2005 Oct; 23(30):7669-75. PubMed ID: 16234529
[TBL] [Abstract][Full Text] [Related]
2. Head-and-neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators.
Dai Z; He Y; Zhang X; Tian Z; Zhu G; Ren Z; Ye L; Liu Z; Ma C; Cao W; Ji T
Oral Dis; 2024 Apr; 30(3):1040-1051. PubMed ID: 36597156
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy.
Fields RC; Hameed M; Qin LX; Moraco N; Jia X; Maki RG; Singer S; Brennan MF
Ann Surg Oncol; 2011 Feb; 18(2):328-36. PubMed ID: 20844969
[TBL] [Abstract][Full Text] [Related]
4. Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients.
Muto Y; Fujimura T; Takahashi A; Namikawa K; Ogata D; Nakano E; Jinnai S; Hashimoto A; Kambayashi Y; Asano Y; Yamazaki N
J Dermatol; 2024 May; ():. PubMed ID: 38775205
[TBL] [Abstract][Full Text] [Related]
5. Current treatment options for dermatofibrosarcoma protuberans.
Rutkowski P; Debiec-Rychter M
Expert Rev Anticancer Ther; 2015; 15(8):901-9. PubMed ID: 26027711
[TBL] [Abstract][Full Text] [Related]
6. Current treatment options in dermatofibrosarcoma protuberans.
Lemm D; Mügge LO; Mentzel T; Höffken K
J Cancer Res Clin Oncol; 2009 May; 135(5):653-65. PubMed ID: 19205737
[TBL] [Abstract][Full Text] [Related]
7. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
8. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibrosarcoma Protuberans: What Is This?
Vitiello GA; Lee AY; Berman RS
Surg Clin North Am; 2022 Aug; 102(4):657-665. PubMed ID: 35952694
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma Protuberans.
Allen A; Ahn C; Sangüeza OP
Dermatol Clin; 2019 Oct; 37(4):483-488. PubMed ID: 31466588
[TBL] [Abstract][Full Text] [Related]
11. S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018.
Ugurel S; Kortmann RD; Mohr P; Mentzel T; Garbe C; Breuninger H; Bauer S; Grabbe S
J Dtsch Dermatol Ges; 2019 Jun; 17(6):663-668. PubMed ID: 31115967
[TBL] [Abstract][Full Text] [Related]
12. Dermatofibrosarcoma Protuberans.
Acosta AE; Vélez CS
Curr Treat Options Oncol; 2017 Aug; 18(9):56. PubMed ID: 28795284
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous dermatofibrosarcoma protuberans, a rare subtype with predilection for the head: A retrospective series of 18 cases.
Llombart B; Serra-Guillén C; Rubio L; Nagore E; Requena C; Traves V; Calomarde L; Bancalari B; López-Guerrero JA; Guillen-Barona C; Sanmartín O
J Am Acad Dermatol; 2017 Sep; 77(3):503-511.e1. PubMed ID: 28420485
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
[TBL] [Abstract][Full Text] [Related]
15. Dermatofibrosarcoma protuberans of the breast: a case report.
Sin FN; Wong KW
Clin Imaging; 2011; 35(5):398-400. PubMed ID: 21872132
[TBL] [Abstract][Full Text] [Related]
16. Dermatofibrosarcoma protuberans: recent clinical progress.
McArthur G
Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
Abbott JJ; Oliveira AM; Nascimento AG
Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
[TBL] [Abstract][Full Text] [Related]
18. Fibrosarcomatous dermatofibrosarcoma protuberans: a rapidly growing 30 cm mass on the posterior scalp.
Lerttiendamrong B; Annoppornchai P; Promniyom P
Asian Biomed (Res Rev News); 2023 Aug; 17(4):200-205. PubMed ID: 37860677
[TBL] [Abstract][Full Text] [Related]
19. Multi-omic profiling and real time ex vivo modelling of imatinib-resistant dermatofibrosarcoma protuberans with fibrosarcomatous transformation.
Chan JY; Lee ECY; Li Z; Lee JY; Lim AH; Poon E
Hum Cell; 2023 Nov; 36(6):2228-2236. PubMed ID: 37610680
[TBL] [Abstract][Full Text] [Related]
20. Survival Outcomes and Prognostic Factors of Dermatofibrosarcoma Protuberans: A Population-Based Retrospective Cohort Analysis.
Chen S; Xiong L; Zhao L; Li Y; Li L
Dermatol Surg; 2023 Sep; 49(9):825-831. PubMed ID: 37384896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
